Cannabis Science Signs Multi-Company Acquisition & Licensing Deals that will Boost Revenues, Its Pharmaceutical Operations and Management Team While B

Cannabis Science, Inc. CBIS +44.62% , a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce that it has signed a major multi-company acquisition agreement that will boost revenues, strengthen pharmaceutical operations and our management team.These additions will enhance our internal operations and help to fast track our full line of Cannabis Science Brand pharmaceutical and over the counter products through multiple distribution channels to be made available nationally. Over the coming days there will be several announcements outlining the outstanding growth opportunities that will be enhanced by these deals.Cannabis Science Inc., President & CEO, Dr Robert Melamede Ph.D., stated, "These deals put Cannabis Science in a very strong position to grow our Company quickly. We have increased our corporate structure to handle the impressive growth opportunities that are unfolding before us. We have already begun a limited production of the Cannabis Science brand product line with their successful therapeutic functionality demonstrated by the case studies of cancer patients that are posted on the Cannabis Science homepageIt has taken time and effort to develop many important relationships, the first of which are now coming to fruition. These advancements will take Cannabis Science to the next level with multiple products that will have multiple distribution channels nationwide. These deals include strategic relationships with pharmacists and the exclusive production of organically grown strains for our scientific medicinal formulations. Additional accessory businesses will include laboratory capacity for product quality assurance and testing, and educational platforms to produce and distribute information about the science of cannabis that will further our cause through education."The main elements of this group of deals are the following:1. New Executive Management Appointments2. Licensing agreement for exclusive strains, lab facilities, and commercial manufacturing.3. A "Cannabis University" acquisition to be converted to Cannabis Science Brand4. New Cannabis Science Brand product lines5. Multiple national product distribution channels6. Focused continued growth plan based on operational expertise and market opportunities7. Critical ailment target expansionsApothecary Genetics, a cannabis seed breeding company signed a licensing agreement with Cannabis Science. Apothecary will produce several Cannabis Science Brand Formulations for the California medical cannabis market. As well, Apothecary will provide research and development facilities with full circle operations including a California laboratory facility for internal research and development, along with 16 unique genetic strains specifically generated and maintained by a cancer survivor who recognizes the importance of proper growth and breeding.GGECO University, an online video-based medical cannabis education system, offering courses dealing with medical cannabis law, the benefits of medical marijuana, cooking, horticulture, and bud tending, has been acquired by Cannabis Science, following the university's name to Cannabis Science University. Cannabis Science hopes to use this platform to educate the general public, patients, and even those who have already been involved in the medical cannabis industry on the medical benefits of cannabis, how it is grown, how to use it safely, and the many applications or ways to administer the medication.